Aliah R. Alshanwani

Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function

Kirsten Riches‐Suman, Aliah R. Alshanwani, Philip Warburton et al. · Journal of Molecular and Cellular Cardiology · 2014 · 68 citations · Full text

Life Sciences, Biomedical Sciences, Molecular Biology +15

The protective effect of thymoquinone or/and thymol against monosodium glutamate-induced attention-deficit/hyperactivity disorder (ADHD)-like behavior in rats: Modulation of Nrf2/HO-1, TLR4/NF-κB/NLRP3/caspase-1 and Wnt/β-Catenin signaling pathways in rat model

Karema Abu‐Elfotuh, Somaia A Abdel-Sattar, Ashwaq Najemaldeen Abbas et al. · Biomedicine & Pharmacotherapy · 2022 · 56 citations · Full text

Medicine, Neuroscience, Pharmacology +12

A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases

Aliah R. Alshanwani, Hanan Hagar, Sameerah Shaheen et al. · European Journal of Pharmacology · 2022 · 35 citations

Medicine, Pharmacology, Pharmacotherapy +17

MicroRNA‐21 drives the switch to a synthetic phenotype in human saphenous vein smooth muscle cells

Aliah R. Alshanwani, Kirsten Riches‐Suman, David O’Regan et al. · IUBMB Life · 2018 · 26 citations · Full text

Life Sciences, Biomedical Sciences, Cardiology +11

Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson’s Rats: Preventing Mitochondrial, Motor and Histopathological Defects

Metab Alharbi, Abdulrahman Alshammari, Gurpreet Kaur et al. · Molecules · 2022 · 25 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17